This product was introduced as a needle-free alternative to injectable GLP-1 medications
However, the peptide with the introduced palmitic acid exhibited a significantly reduced water solubility
It contains 12.3% Centella asiatica extract, renowned for its anti-inflammatory and healing properties, while 1,000 ppm of glutathione and niacinamide work to even out skin tone, boost elasticity, and protect against oxidative stress
Semaglutide : Approved since 2017 with 7+ years post-marketing data
Microtubule-Associated protein 1B is a component of cortical lewy bodies and binds Alpha-Synuclein filaments
Next Steps and Research Collaboration The next stage in development is a larger phase II clinical trial planned by Atrogi AB, the company leading the drug's advancement